Effects of an Olive Oil-enriched Diet on Glucagon-like Peptide 1 Release and Intestinal Content, Plasma Insulin Concentration, Glucose Tolerance and Pancreatic Insulin Content in an Animal Model of Type 2 Diabetes

Abstract

In the light of a recent study conducted in normal rats, the present investigations were aimed at exploring the immediate and long-term effects of an olive oil-enriched diet (OO diet) on GLP-1 release and intestinal content, plasma insulin concentration, glucose tolerance and pancreatic insulin content in adult rats that had been injected with streptozotocin during the neonatal period (STZ rats). The OO diet, when compared to a standard diet, increased the immediate GLP-1 response in meal-trained rats, but decreased GLP-1 content in the intestinal tract after 50 days. Over 50 days, the body weight gain was lower in the rats fed the OO diet compared to standard diet. In the former, however, no improvement of glucose tolerance or insulin response during an oral glucose tolerance test was observed. Thus, a paradoxical lowering of the insulinogenic index, i. e. the paired ratio between plasma insulin and glucose concentration, was recorded during the oral glucose tolerance test in rats fed either standard or OO diet. Moreover, the insulin content of the pancreas was equally low in the STZ rats fed either standard or OO diet. These findings will be discussed in the framework of possible differences in the pathophysiology of B-cell dysfunction in most patients with type-2 diabetes and the present animal model of non-insulin-dependent diabetes.

Key words

Insulin secretion - streptozotocin-induced diabetic rats - incretin hormone - monounsaturated fatty acids

References

• 1 Prieto G, Cancelas J, Villanueva-Peñacarrillo M L, Valverde I, Malaisse W J. Effects of an olive oil-enriched diet on plasma GLP-1 concentration and intestinal content, plasma insulin concentration, and glucose tolerance in normal rats.  Endocrine. 2005;  26 107-116
• 2 Dubé P E, Brubaker P L. Nutrient, neural and endocrine control of glucagon-like peptide secretion.  Horm Metab Res. 2004;  36 755-760
• 3 Dhillo W S, Bloom S R. Gastrointestinal hormones and regulation of food intake.  Horm Metab Res. 2004;  36 846-851
• 4 Egido E M, Silvestre R A, Hernández R, Marco J. Exendin-4 dose-dependently stimulates somatostatin and insulin secretion in perfused rat pancreas.  Horm Metab Res. 2004;  36 595-600
• 5 Holz G. New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic β-cells.  Horm Metab Res. 2004;  36 787-794
• 6 Storlien L H, James D E, Burleigh K M, Chisholm D J, Kraegen E W. Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats.  Am J Physiol. 1986;  251 E576-E583
• 7 Holness M J, Krause A, Harris R A, Sugden M C. Targeted regulation of pyruvate dehydrogenase kinae (PDK)-4 in slow-twitch skeletal muscle underlies the stable modification of the regulatory characteristics of PDK induced by high-fat feeding.  Diabetes. 2000;  49 775-781
• 8 Portha B, Picon L, Rosselin G. Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes.  Diabetologia. 1974;  17 371-377
• 9 Vicent D, Villanueva-Peñacarrillo M L, Valverde I, Malaisse W J. Impaired in vivo insulin secretion in response to non-glucidic secretagogues in adult rats after neonatal streptozotocin.  Acta Diabetol. 1994;  31 133-137
• 10 Bergmeyer H U, Berndt E. Glucose determination with glucose oxidase and peroxidase. In: Bergmeyer HU (ed) Methods of Enzymatic Analysis. New York; Academic Press 1974: 1205-1215
• 11 Valverde I, Barreto M, Malaisse W J. Stimulation by D-glucose of protein biosynthesis in tumoral insulin-producing cells (RINm5F line).  Endocrinology. 1988;  122 1443-1448
• 12 Orskov C, Holst J J. Radioimmunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2).  Scand J Clin Lab Invest. 1987;  47 165-174
• 13 Valverde I, Wang G-S, Burghardt K, Kauri L M, Redondo A, Acitores A, Villanueva-Peñacarrillo M L, Courtois P, Sener A, Cancelas J, Malaisse W J, Scott F W. Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats.  Endocrine. 2004;  23 77-84
• 14 Cancelas J, Sancho V, Villanueva-Penacarrillo M L, Courtois P, Scott F W, Valverde I, Malaisse W J. Glucagon-like peptide 1 content of intestinal tract in adult rats injected with streptozotocin either during neonatal period or 7 d before sacrifice.  Endocrine. 2002;  19 279-286
• 15 Jackson R L, Shuey E W, Grinnan E L, Ellis R M. Preparation and partial characteritation of crystalline human insulin.  Diabetes. 1969;  4 206-211
• 16 Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.  Anal Biochem. 1976;  72 248-254
• 17 Luttichau H R, Van Solinge W W, Nielsen F C, Rehfeld J F. Developmental expression of the gastrin and cholecystokine genes in rat colon.  Gastroenterology. 1993;  104 1092-1098
• 18 Malaisse W J. Physiology of insulin secretion and its alteration in diabetes: the concept of glucotoxicity. In: Adreani D, Gueriguian JL, Striker GE (eds) Diabetic complications: epidemiology and phatogenic mechanisms. New York; Raven Press 1991: 73-92
• 19 Garg A, Bantle J P, Henry R R, Coulston A M, Griver K A, Raatz S K, Brikley L, Chen Y D, Grandy S M, Huet B A. Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitus.  J Am Med Assoc. 1994;  271 1421-1428
• 20 Low C C, Grossman E B, Gumbiner B. Potentiation of effects of weight loss by monounsaturated fatty acids in obese NIDDM patients.  Diabetes. 1996;  45 569-575